Coronavirus Risk Checklist for Companies Operating in the Healthcare and Life Sciences Sector

As the 2019 Novel Coronavirus (COVID-19) continues to spread across the world, the challenges for companies operating in the healthcare and life sciences sector are increasing. The EMEA Healthcare Industry Group has prepared a checklist of the new risks emerging for companies operating in the healthcare and life sciences sector as a result of the outbreak.

This document looks at general issues, such as

• employment law
• compliance risks
• contractual liabilities
• insurance
• impact on the supply chain
• tax matters
• risk disclosures

and also at healthcare specific issues, such as

• shortages of medicines, medical devices and biocides
• competition law, IP law-related matters as a result of the disruptions caused by the outbreak
• impact on clinical trials
• consequences for digital health
• effects on market access of medicines
• joint procurement actions

Download checklist